CAS No. |
2590-41-2 |
|---|---|
英文名称 |
(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate |
别名 |
17-ACETOXYESTRA-4,6-DIEN-3-ONE;17b-Acetyloxy-estra-4,6-diene-3-one;DEHYDRONANDROLON;4,6-ESTRADIEN-17-BETA-OL-3-ONE ACETATE;6-DEHYDRONANDROLONE ACETATE;(8R,9S,13S,14S,17S)-13-Methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate;Dehydronandrolone Acetate;Dehydronandrolone-6 Acetate |
标准英文名 |
(8R,9S,10R,13S,14S,17S)-13-methyl-3-oxo-2,3,8,9,10,11,12,13,14,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl acetate |
分子式 |
C20H26O3 |
分子量 |
314.42 |
精确分子量 |
314.19 |
SMILES |
CC(=O)O[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@H]4[C@H]3CC[C@]12C |
标准SMILES |
CC(=O)O[C@H]1CC[C@H]2[C@@H]3C=CC4=CC(=O)CC[C@@H]4[C@H]3CC[C@@]21C |
用途 |
Dehydronandrolone acetate is used as a starting material in the synthesis of fulvestrant, an estrogen receptor antagonist employed in breast cancer research. |
InChIKey |
OGUASZAAVFYYIL-XGXHKTLJSA-N |
|
|
评论 |
|---|